Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ocular Therapeutix Inc (NASDAQ:OCUL)

4.69
Delayed Data
As of Dec 13
 +0.42 / +9.84%
Today’s Change
3.30
Today|||52-Week Range
11.79
-43.97%
Year-to-Date
No recent news for Ocular Therapeutix Inc.

Today’s Trading

Previous close4.27
Today’s open4.29
Day’s range4.29 - 4.73
Volume389,085
Average volume (3 months)353,009
Market cap$124.1M
Data as of 4:00pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)-5.26%
Earnings growth (this year)-28.24%
Earnings growth (next 5 years)+43.00%
Revenue growth (last year)+7.83%
P/E ratioNM
Price/Sales110.08
Price/Book2.05

Competitors

 Today’s
change
Today’s
% change
CRHMCRH Medical Corp-0.02-1.11%
MACKMerrimack Pharmaceut...+0.20+1.97%
SBPHSpring Bank Pharmace...+0.15+1.20%
CLSDClearside Biomedical...-0.29-4.33%
Data as of 4:00pm ET, 12/13/2017

Financials

Next reporting dateMarch 9, 2018
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$1.9M
Annual profit (last year)-$44.7M
Net profit margin-2,369.00%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President &
Chief Executive Officer
Antony Mattessich
Chief Accounting &
Operating Officer
James Fortune
Corporate headquarters
Bedford, Massachusetts

Forecasts